News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Ironwood Pharmaceuticals, Inc.
< Previous
1
2
Next >
Ironwood Pharmaceuticals Reports Second Quarter 2024 Results
August 08, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call
July 25, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
May 30, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
May 21, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals Reports First Quarter 2024 Results
May 09, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference
May 06, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024
May 01, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
April 25, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)
March 28, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
February 29, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
February 23, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
February 15, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update Call
February 01, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Announces Publication in The Lancet Gastroenterology & Hepatology of New Linaclotide Phase III Data in Children and Adolescents Aged 6-17 Years with Functional Constipation
January 08, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance
January 08, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio
December 12, 2023
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals to Participate in the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
November 09, 2023
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals to Host Third Quarter 2023 Investor Update Call
October 26, 2023
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Releases New IBS-C and CIC Data at the American College of Gastroenterology 2023 Annual Scientific Meeting
October 23, 2023
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals Presents Positive Final Data from STARS Nutrition, a Phase II Study of Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) and Colon in Continuity (CIC) at United European Gastroenterology Week
October 16, 2023
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood to Present New Data at NASPGHAN Annual Meeting Reinforcing Impact of Linaclotide on Functional Constipation in Children and Adolescents Ages 6-17 Years-Old
October 05, 2023
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance
August 08, 2023
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals to Host Second Quarter 2023 Investor Update Call
July 25, 2023
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares
June 29, 2023
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
VECT
Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio
June 16, 2023
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
VECT
Ironwood Pharmaceuticals Announces FDA Approval of New Indication for LINZESS® (linaclotide) for the Treatment of Functional Constipation in Pediatric Patients Ages 6-17 Years-Old
June 12, 2023
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases
May 22, 2023
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
Ironwood Pharmaceuticals to Participate in The JMP Securities Life Sciences Conference
May 09, 2023
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Tickers
IRWD
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.